{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:06:25Z","timestamp":1780092385515,"version":"3.54.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00106-021-01110-4","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T18:02:11Z","timestamp":1634148131000},"page":"931-942","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epistaxis\u00a0\u2013 \u00dcbersicht und aktuelle Aspekte","Epistaxis\u2014overview and current aspects"],"prefix":"10.1007","volume":"69","author":[{"given":"Kruthika","family":"Thangavelu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"K\u00f6hnlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behfar","family":"Eivazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Gurschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris A.","family":"Stuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"Geisthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"1110_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/0194599819889955","volume":"162","author":"DE Tunkel","year":"2020","unstructured":"Tunkel\u00a0DE, Anne\u00a0S, Payne\u00a0SC et\u00a0al (2020) Clinical practice guideline: nosebleed (Epistaxis) executive summary. Otolaryngol Head Neck Surg 162:8\u201325","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1110_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.joms.2005.11.031","volume":"64","author":"TL Viehweg","year":"2006","unstructured":"Viehweg\u00a0TL, Roberson\u00a0JB, Hudson\u00a0JW (2006) Epistaxis: diagnosis and treatment. J\u00a0Oral Maxillofac Surg 64:511\u2013518","journal-title":"J Oral Maxillofac Surg"},{"key":"1110_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.otohns.2004.05.009","volume":"131","author":"MS Benninger","year":"2004","unstructured":"Benninger\u00a0MS, Marple\u00a0BF (2004) Minor recurrent epistaxis: prevalence and a\u00a0new method for management. Otolaryngol Head Neck Surg 131:317\u2013320","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1110_CR4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/lary.23225","volume":"122","author":"SE Cooper","year":"2012","unstructured":"Cooper\u00a0SE, Ramakrishnan\u00a0VR (2012) Direct cauterization of the nasal septal artery for epistaxis. Laryngoscope 122:738\u2013740","journal-title":"Laryngoscope"},{"key":"1110_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.otc.2016.01.003","volume":"49","author":"G Lin","year":"2016","unstructured":"Lin\u00a0G, Bleier\u00a0B (2016) Surgical management of severe epistaxis. Otolaryngol Clin North Am 49:627\u2013637","journal-title":"Otolaryngol Clin North Am"},{"key":"1110_CR6","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00405-018-5043-z","volume":"275","author":"AMS Buchberger","year":"2018","unstructured":"Buchberger\u00a0AMS, Baumann\u00a0A, Johnson\u00a0F et\u00a0al (2018) The role of oral anticoagulants in epistaxis. Eur Arch Otorhinolaryngol 275:2035\u20132043","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1110_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pop.2013.10.007","volume":"41","author":"DJ Morgan","year":"2014","unstructured":"Morgan\u00a0DJ, Kellerman\u00a0R (2014) Epistaxis: evaluation and treatment. Prim Care 41:63\u201373","journal-title":"Prim Care"},{"key":"1110_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.anorl.2016.09.008","volume":"134","author":"E Bequignon","year":"2017","unstructured":"Bequignon\u00a0E, V\u00e9rillaud\u00a0B, Robard\u00a0L et al (2017) Guidelines of the French Society of Otorhinolaryngology (SFORL). First-line treatment of epistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis 134:185\u2013189","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"1110_CR9","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1017\/S0022215117002018","volume":"131","author":"NENTTR NETWORK","year":"2017","unstructured":"NENTTR NETWORK (2017) The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis. J\u00a0Laryngol Otol 131:1142\u20131156","journal-title":"J\u00a0Laryngol Otol"},{"key":"1110_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.otorri.2014.02.014","volume":"65","author":"FJ Garc\u00eda Callejo","year":"2014","unstructured":"Garc\u00eda Callejo\u00a0FJ, B\u00e9cares Mart\u00ednez\u00a0C, Calvo Gonz\u00e1lez\u00a0J et al (2014) Epistaxis and dabigatran, a\u00a0new non-vitamin K antagonist oral anticoagulant. Acta Otorrinolaringol Esp 65:346\u2013354","journal-title":"Acta Otorrinolaringol Esp"},{"key":"1110_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11239-017-1506-0","volume":"44","author":"MPA Brekelmans","year":"2017","unstructured":"Brekelmans\u00a0MPA, Ginkel\u00a0KV, Daams\u00a0JG et al (2017) Benefits and harms of 4\u2011factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a\u00a0systematic review and meta-analysis. J\u00a0Thromb Thrombolysis 44:118\u2013129","journal-title":"J Thromb Thrombolysis"},{"key":"1110_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11239-008-0211-4","volume":"27","author":"G Denas","year":"2009","unstructured":"Denas\u00a0G, Marzot\u00a0F, Offelli\u00a0P et al (2009) Effectiveness and safety of a\u00a0management protocol to correct over-anticoagulation with oral vitamin K: a\u00a0retrospective study of 1,043\u00a0cases. J\u00a0Thromb Thrombolysis 27:340\u2013347","journal-title":"J Thromb Thrombolysis"},{"key":"1110_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ajem.2017.07.025","volume":"36","author":"M Hajimaghsoudi","year":"2018","unstructured":"Hajimaghsoudi\u00a0M, Largani\u00a0HA, Baradaranfar\u00a0MH et\u00a0al (2018) A novel method for epistaxis management: randomized clinical trial comparing nose clip with manual compression. Am J Emerg Med 36:149\u2013150","journal-title":"Am J Emerg Med"},{"key":"1110_CR14","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1017\/S0022215114002886","volume":"128","author":"M Ozturk","year":"2014","unstructured":"Ozturk\u00a0M, Mutlu\u00a0F, Kara\u00a0A et\u00a0al (2014) Evaluation of the effect of nasal dorsal skin cooling on nasal mucosa by acoustic rhinometry. J\u00a0Laryngol Otol 128:1067\u20131070","journal-title":"J Laryngol Otol"},{"key":"1110_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.annemergmed.2019.03.030","volume":"74","author":"S Akkan","year":"2019","unstructured":"Akkan\u00a0S, \u00c7orbac\u0131o\u011flu \u015eK, Aytar\u00a0H et\u00a0al (2019) Evaluating effectiveness of nasal compression with tranexamic acid compared with simple nasal compression and merocel packing: a randomized controlled trial. Ann Emerg Med 74:72\u201378","journal-title":"Ann Emerg Med"},{"key":"1110_CR16","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ajem.2013.06.043","volume":"31","author":"R Zahed","year":"2013","unstructured":"Zahed\u00a0R, Moharamzadeh\u00a0P, Alizadeharasi\u00a0S et\u00a0al (2013) A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a\u00a0randomized controlled trial. Am J Emerg Med 31:1389\u20131392","journal-title":"Am J Emerg Med"},{"key":"1110_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1017\/S0022215117002043","volume":"131","author":"RWJ Mcleod","year":"2017","unstructured":"Mcleod\u00a0RWJ, Price\u00a0A, Williams\u00a0RJ et\u00a0al (2017) Intranasal cautery for the management of adult epistaxis: systematic review. J\u00a0Laryngol Otol 131:1056\u20131064","journal-title":"J Laryngol Otol"},{"key":"1110_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1017\/S0022215117002031","volume":"131","author":"M Khan","year":"2017","unstructured":"Khan\u00a0M, Conroy\u00a0K, Ubayasiri\u00a0K et\u00a0al (2017) Initial assessment in the management of adult epistaxis: systematic review. J\u00a0Laryngol Otol 131:1035\u20131055","journal-title":"J Laryngol Otol"},{"key":"1110_CR19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/000348949510400906","volume":"104","author":"GA Krempl","year":"1995","unstructured":"Krempl\u00a0GA, Noorily\u00a0AD (1995) Use of oxymetazoline in the management of epistaxis. Ann Otol Rhinol Laryngol 104:704\u2013706","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"1110_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1017\/S0022215115000663","volume":"129","author":"MK Khan","year":"2015","unstructured":"Khan\u00a0MK, Reda El Badawey\u00a0M, Powell\u00a0J et\u00a0al (2015) The utility of FloSeal haemostatic agent in the management of epistaxis. J\u00a0Laryngol Otol 129:353\u2013357","journal-title":"J Laryngol Otol"},{"key":"1110_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00405-006-0047-5","volume":"263","author":"I Moumoulidis","year":"2006","unstructured":"Moumoulidis\u00a0I, Draper\u00a0MR, Patel\u00a0H et\u00a0al (2006) A prospective randomised controlled trial comparing merocel and rapid rhino nasal tampons in the treatment of epistaxis. Eur Arch Otorhinolaryngol 263:719\u2013722","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1110_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-21131-7","volume-title":"Hals-Nasen-Ohren-Heilkunde","author":"T Lenarz","year":"2012","unstructured":"Lenarz T, Boenninghaus H-G (2012) Hals-Nasen-Ohren-Heilkunde. Springer, Berlin, Heidelberg"},{"key":"1110_CR23","first-page":"1","volume":"34","author":"SW Mcclurg","year":"2014","unstructured":"Mcclurg\u00a0SW, Carrau\u00a0R (2014) Endoscopic management of posterior epistaxis: a\u00a0review. Acta Otorhinolaryngol Ital 34:1\u20138","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"1110_CR24","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00405-008-0657-1","volume":"265","author":"T Upile","year":"2008","unstructured":"Upile\u00a0T, Jerjes\u00a0W, Sipaul\u00a0F et\u00a0al (2008) A change in UK epistaxis management. Eur Arch Otorhinolaryngol 265:1349\u20131354","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1110_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1017\/S0022215111003215","volume":"126","author":"C Pepper","year":"2012","unstructured":"Pepper\u00a0C, Lo\u00a0S, Toma\u00a0A (2012) Prospective study of the risk of not using prophylactic antibiotics in nasal packing for epistaxis. J\u00a0Laryngol Otol 126:257\u2013259","journal-title":"J Laryngol Otol"},{"key":"1110_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0194-5998(99)70134-8","volume":"121","author":"ED Monte","year":"1999","unstructured":"Monte\u00a0ED, Belmont\u00a0MJ, Wax\u00a0MK (1999) Management paradigms for posterior epistaxis: a comparison of costs and complications. Otolaryngol Head Neck Surg 121:103\u2013106","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1110_CR27","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1067\/mhn.2000.110619","volume":"123","author":"B Civelek","year":"2000","unstructured":"Civelek\u00a0B, Kargi\u00a0AE, Sens\u00f6z\u00a0O et\u00a0al (2000) Rare complication of nasal packing: alar region necrosis. Otolaryngol Head Neck Surg 123:656\u2013657","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1110_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/coa.13555","volume":"45","author":"Integrate","year":"2020","unstructured":"Integrate (2020) INTEGRATE (the UK ENT trainee research network): nasal packs for epistaxis: predictors of success. Clin Otolaryngol 45:659\u2013666","journal-title":"Clin Otolaryngol"},{"key":"1110_CR29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1177\/0194599813492949","volume":"149","author":"J Shargorodsky","year":"2013","unstructured":"Shargorodsky\u00a0J, Bleier\u00a0BS, Holbrook\u00a0EH et\u00a0al (2013) Outcomes analysis in epistaxis management: development of a\u00a0therapeutic algorithm. Otolaryngol Head Neck Surg 149:390\u2013398","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1110_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jemermed.2020.10.011","volume":"60","author":"L Hu","year":"2021","unstructured":"Hu\u00a0L, Gordon\u00a0SA, Swaminathan\u00a0A et\u00a0al (2021) Utilization of prophylactic antibiotics after nasal packing for epistaxis. J\u00a0Emerg Med 60:144\u2013149","journal-title":"J Emerg Med"},{"key":"1110_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ajem.2018.12.056","volume":"37","author":"T Murano","year":"2019","unstructured":"Murano\u00a0T, Brucato-Duncan\u00a0D, Ramdin\u00a0C et al (2019) Prophylactic systemic antibiotics for anterior epistaxis treated with nasal packing in the ED. Am J Emerg Med 37:726\u2013729","journal-title":"Am J Emerg Med"},{"key":"1110_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2500\/ajra.2017.31.4454","volume":"31","author":"JL Lange","year":"2017","unstructured":"Lange\u00a0JL, Peeden\u00a0EH, Stringer\u00a0SP (2017) Are prophylactic systemic antibiotics necessary with nasal packing? A systematic review. Am J Rhinol Allergy 31:240\u2013247","journal-title":"Am J Rhinol Allergy"},{"key":"1110_CR33","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ajem.2019.11.037","volume":"38","author":"QK Tran","year":"2020","unstructured":"Tran\u00a0QK, Rehan\u00a0MA, Haase\u00a0DJ et al (2020) Prophylactic antibiotics for anterior nasal packing in emergency department: a systematic review and meta-analysis of clinically-significant infections. Am J Emerg Med 38:983\u2013989","journal-title":"Am J Emerg Med"},{"issue":"3","key":"1110_CR34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.anl.2015.09.015","volume":"43","author":"J Iimura","year":"2016","unstructured":"Iimura\u00a0J, Hatano\u00a0A, Ando\u00a0Y, Arai\u00a0C, Arai\u00a0S, Shigeta\u00a0Y et\u00a0al (2016) Study of hemostasis procedures for posterior epistaxis. Auris Nasus Larynx 43(3):298\u2013303","journal-title":"Auris Nasus Larynx"},{"key":"1110_CR35","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1288\/00005537-199212000-00016","volume":"102","author":"R Budrovich","year":"1992","unstructured":"Budrovich\u00a0R, Saetti\u00a0R (1992) Microscopic and endoscopic ligature of the sphenopalatine artery. Laryngoscope 102:1391\u20131394","journal-title":"Laryngoscope"},{"key":"1110_CR36","first-page":"321","volume":"23","author":"AC Stamm","year":"1985","unstructured":"Stamm\u00a0AC, Pinto\u00a0JA, Neto\u00a0AF et\u00a0al (1985) Microsurgery in severe posterior epistaxis. Rhinology 23:321\u2013325","journal-title":"Rhinology"},{"key":"1110_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1046\/j.1365-2273.2003.00724.x","volume":"28","author":"S Kumar","year":"2003","unstructured":"Kumar\u00a0S, Shetty\u00a0A, Rockey\u00a0J et\u00a0al (2003) Contemporary surgical treatment of epistaxis. What is the evidence for sphenopalatine artery ligation? Clin Otolaryngol 28:360\u2013363","journal-title":"Clin Otolaryngol"},{"key":"1110_CR38","first-page":"300","volume":"43","author":"B Feusi","year":"2005","unstructured":"Feusi\u00a0B, Holzmann\u00a0D, Steurer\u00a0J (2005) Posterior epistaxis: systematic review on the effectiveness of surgical therapies. Rhinology 43:300\u2013304","journal-title":"Rhinology"},{"key":"1110_CR39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4193\/Rhin17.212","volume":"56","author":"K Piastro","year":"2018","unstructured":"Piastro\u00a0K, Scagnelli\u00a0R, Gildener-Leapman\u00a0N et al (2018) Outcomes of sphenopalatine and internal maxillary artery ligation inside the pterygopalatine fossa for posterior epistaxis. Rhinology 56:144\u2013148","journal-title":"Rhinology"},{"key":"1110_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/01.mlg.0000250778.29957.a1","volume":"117","author":"SD Pletcher","year":"2007","unstructured":"Pletcher\u00a0SD, Metson\u00a0R (2007) Endoscopic ligation of the anterior ethmoid artery. Laryngoscope 117:378\u2013381","journal-title":"Laryngoscope"},{"key":"1110_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1148\/111.2.285","volume":"111","author":"J Sokoloff","year":"1974","unstructured":"Sokoloff\u00a0J, Wickbom\u00a0I, Mcdonald\u00a0D et\u00a0al (1974) Therapeutic percutaneous embolization in intractable epistaxis. Radiology 111:285\u2013287","journal-title":"Radiology"},{"key":"1110_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1055\/s-0033-1353478","volume":"30","author":"GJ Dubel","year":"2013","unstructured":"Dubel\u00a0GJ, Ahn\u00a0SH, Soares\u00a0GM (2013) Transcatheter embolization in the management of epistaxis. Semin intervent Radiol 30:249\u2013262","journal-title":"Semin intervent Radiol"},{"key":"1110_CR43","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s00270-011-0155-5","volume":"34","author":"K Strach","year":"2011","unstructured":"Strach\u00a0K, Schr\u00f6ck\u00a0A, Wilhelm\u00a0K et\u00a0al (2011) Endovascular treatment of epistaxis: indications, management, and outcome. Cardiovasc Intervent Radiol 34:1190\u20131198","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1110_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00106-018-0503-8","volume":"66","author":"F Haubner","year":"2018","unstructured":"Haubner\u00a0F, K\u00fchnel\u00a0T (2018) Diagnosis and treatment of Osler\u2019s disease. HNO 66:405\u2013414","journal-title":"HNO"},{"key":"1110_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin\u00a0CL, Guttmacher\u00a0AE, Buscarini\u00a0E et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66\u201367","journal-title":"Am J Med Genet"},{"issue":"9","key":"1110_CR46","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s001060050141","volume":"45","author":"JA Werner","year":"1997","unstructured":"Werner\u00a0JA, Geisthoff\u00a0UW, Lippert\u00a0BM, Rudert\u00a0H (1997) Behandlung der rezidivierenden Epistaxis beim Morbus Rendu-Osler-Weber. HNO 45(9):673\u2013681","journal-title":"HNO"},{"key":"1110_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan\u00a0ME, Palda\u00a0VA, Garcia-Tsao\u00a0G et al (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J\u00a0Med Genet 48:73\u201387","journal-title":"J Med Genet"},{"key":"1110_CR48","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2174\/138161206776361255","volume":"12","author":"UW Geisthoff","year":"2006","unstructured":"Geisthoff\u00a0UW, Fiorella\u00a0ML, Fiorella\u00a0R (2006) Treatment of recurrent epistaxis in HHT. Curr Pharm Des 12:1237\u20131242","journal-title":"Curr Pharm Des"},{"key":"1110_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051507","author":"U Geisthoff","year":"2020","unstructured":"Geisthoff\u00a0U, Nguyen\u00a0HL, Lefering\u00a0R et\u00a0al (2020) Trauma can induce telangiectases in hereditary hemorrhagic telangiectasia. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9051507","journal-title":"J Clin Med"},{"key":"1110_CR50","doi-asserted-by":"publisher","first-page":"989","DOI":"10.7326\/M20-1443","volume":"173","author":"ME Faughnan","year":"2020","unstructured":"Faughnan\u00a0ME, Mager\u00a0JJ, Hetts\u00a0SW et\u00a0al (2020) Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med 173:989\u20131001","journal-title":"Ann Intern Med"},{"key":"1110_CR51","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.otohns.2006.12.019","volume":"136","author":"UW Geisthoff","year":"2007","unstructured":"Geisthoff\u00a0UW, Heckmann\u00a0K, D\u2019amelio\u00a0R et al (2007) Health-related quality of life in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 136:726\u2013733 (discussion 734\u2013725)","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1110_CR52","first-page":"231","volume":"57","author":"F Droege","year":"2019","unstructured":"Droege\u00a0F, Lueb\u00a0C, Thangavelu\u00a0K et al (2019) Nasal self-packing for epistaxis in hereditary hemorrhagic telangiectasia increases quality of life. Rhinology 57:231\u2013239","journal-title":"Rhinology"},{"key":"1110_CR53","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1055\/s-2007-997466","volume":"76","author":"M Fischer","year":"1997","unstructured":"Fischer\u00a0M, Dietrich\u00a0U, Labisch\u00a0C et al (1997) Critical evaluation of vascular embolization in patients with Rendu-Osler disease. Laryngorhinootologie 76:490\u2013494","journal-title":"Laryngorhinootologie"},{"key":"1110_CR54","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/bjh.13606","volume":"171","author":"UW Geisthoff","year":"2015","unstructured":"Geisthoff\u00a0UW, Nguyen\u00a0HL, R\u00f6th\u00a0A et\u00a0al (2015) How to manage patients with hereditary haemorrhagic telangiectasia. Br J Haematol 171:443\u2013452","journal-title":"Br J Haematol"},{"key":"1110_CR55","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/jth.12654","volume":"12","author":"S Gaillard","year":"2014","unstructured":"Gaillard\u00a0S, Dupuis-Girod\u00a0S, Boutitie\u00a0F et al (2014) Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a\u00a0European cross-over controlled trial in a\u00a0rare disease. J\u00a0Thromb Haemost 12:1494\u20131502","journal-title":"J Thromb Haemost"},{"key":"1110_CR56","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.thromres.2014.06.012","volume":"134","author":"UW Geisthoff","year":"2014","unstructured":"Geisthoff\u00a0UW, Seyfert\u00a0UT, K\u00fcbler\u00a0M et al (2014) Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid\u2014A\u00a0double-blind placebo-controlled cross-over phase IIIB study. Thromb Res 134:565\u2013571","journal-title":"Thromb Res"},{"key":"1110_CR57","first-page":"85","volume":"47","author":"EM De Gussem","year":"2009","unstructured":"De Gussem\u00a0EM, Snijder\u00a0RJ, Disch\u00a0FJ et al (2009) The effect of N\u2011acetylcysteine on epistaxis and quality of life in patients with HHT: a\u00a0pilot study. Rhinology 47:85\u201388","journal-title":"Rhinology"},{"key":"1110_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13023-018-0982-4","volume":"14","author":"E Buscarini","year":"2019","unstructured":"Buscarini\u00a0E, Botella\u00a0LM, Geisthoff\u00a0U et\u00a0al (2019) Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis 14:28","journal-title":"Orphanet J Rare Dis"},{"key":"1110_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.otohns.2008.01.005","volume":"138","author":"CG Levine","year":"2008","unstructured":"Levine\u00a0CG, Ross\u00a0DA, Henderson\u00a0KJ et al (2008) Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 138:721\u2013724","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1110_CR60","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2500\/ajra.2012.26.3809","volume":"26","author":"SL Richer","year":"2012","unstructured":"Richer\u00a0SL, Geisthoff\u00a0UW, Livada\u00a0N et\u00a0al (2012) The Young\u2019s procedure for severe epistaxis from hereditary hemorrhagic telangiectasia. Am J Rhinol Allergy 26:401\u2013404","journal-title":"Am J Rhinol Allergy"},{"key":"1110_CR61","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/lary.20065","volume":"119","author":"E Yaniv","year":"2009","unstructured":"Yaniv\u00a0E, Preis\u00a0M, Hadar\u00a0T et al (2009) Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a\u00a0double-blind placebo-controlled clinical trial. Laryngoscope 119:284\u2013288","journal-title":"Laryngoscope"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-021-01110-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-021-01110-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-021-01110-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T02:08:46Z","timestamp":1635214126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-021-01110-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1007\/s00106-021-01110-4","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"assertion":[{"value":"15 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"K.\u00a0Thangavelu: A.\u00a0Finanzielle Interessen: K.\u00a0Thangavelu gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Fach\u00e4rztin f\u00fcr HNO Heilkunde, Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Marburg\u00a0| Mitgliedschaft: Deutsche Gesellschaft f\u00fcr HNO Heilkunde.S.\u00a0K\u00f6hnlein: A.\u00a0Finanzielle Interessen: S.\u00a0K\u00f6hnlein gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte Assistenz\u00e4rztin f\u00fcr HNO Heilkunde UKGM Standort Marburg.B.\u00a0Eivazi: A.\u00a0Finanzielle Interessen: B.\u00a0Eivazi gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Niedergelassener HNO-Arzt, Darmstadt.M.\u00a0Gurschi: A.\u00a0Finanzielle Interessen: M.\u00a0Gurschi gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin Neuroradiologin, Unu-klinikum Marburg\u00a0| Mitgliedschaften: DRG; DGNR; DeGIR.B.\u00a0Stuck: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: BAS hat finanzielle Unterst\u00fctzung f\u00fcr Forschungsarbeiten, Berater- und Referentenhonorare von folgenden Firmen erhalten: Sutter Medizintechnik, Neuwirth Medical Products. Er hat dar\u00fcber hinaus finanzielle Unterst\u00fctzung (Sponsoring) f\u00fcr Veranstaltungen der Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde Marburg erhalten von: Medtronic GmbH, Karl Storz GmbH, Spiggle&Theis Medizintechnik, bess medizintechnik, Neuwirth Medical Products, Otopront.\u00a0\u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: BAS hat finanzielle Unterst\u00fctzung f\u00fcr Forschungsarbeiten, Berater- und Referentenhonorare von folgenden Firmen erhalten: Sutter Medizintechnik, Neuwirth Medical Products. Er hat dar\u00fcber hinaus finanzielle Unterst\u00fctzung (Sponsoring) f\u00fcr Veranstaltungen der Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde Marburg erhalten von: Medtronic GmbH, Karl Storz GmbH, Spiggle&Theis Medizintechnik, bess medizintechnik, Neuwirth Medical Products, Otopront.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Direktor der Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinikum Marburg\u00a0| Ordinatrius f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Philipps-Universit\u00e4t Marburg\u00a0| Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Kopf- und Hals-Chirurgie e.V.\u00a0| Deutscher Berufsverband der HNO-\u00c4rzte.U.\u00a0Geisthoff: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Cook Medical: Ger\u00e4te, EMS: Ger\u00e4te, Walz EL: Geld und Ger\u00e4te.\u00a0\u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: UKGM: Teilnehmergeb\u00fchren, Reisekosten, M.\u00a0Osler-Selbsthilfe: Teilnehmergeb\u00fchren, Reise- und \u00dcbernachtungskosten, CureHHT: Reise- und \u00dcbernachtungskosten, Uniklinik Jena: Reis- und \u00dcbernachtungskosten, Uniklinik Erlangen: Honorar, Reise- und \u00dcbernachtungskosten.\u00a0\u2013 Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00e4.: Clalit: Honorar, Reise- und \u00dcbernachtungskosten f\u00fcr Operationen und \u00e4rztliche Fortbildung.\u00a0\u2013 Patente, Gesch\u00e4ftsanteile, Aktien o.\u202f\u00e4. an einer im Medizinbereich aktiven Firma: Aktien: Biontech, Curevac, Inspire Medical.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Gesch\u00e4ftsf\u00fchrender Oberarzt, HNO Uniklinik Essen bis 2017, stellvertretender Klinikdirektor, HNO UKGM Standort Marburg ab 2017, M.\u00a0Osler-Selbsthilfe e.\u202fV.\u00a0\u2013 bundesweit: 3.\u00a0Vorsitzender , Osler-Stiftung: Vorsitzender des Kuratoriums\u00a0| Mitgliedschaften: DGHNO, AAO-HNSF, DiGGefA, Bundesverband angeborene Gef\u00e4\u00dffehlbildungen e.\u202fV., Health Care Provider Representative, HHT Working Group, VASCERN bis 2017, CureHHT\/HHT Foundation International: Mitglied des \u201eGlobal Research and Medical Advisory Board\u201c, Mitautor beider \u201eHHT International Guidelines\u201c.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}